Drug Development Tools Research Grants (U01) Clinical Trials Optional
Key Information
Due Date: May 13, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $500,000
Funding Type: Cooperative Agreement, Government
Match Required: No
Contact Info:
terrin.brown@fda.hhs.gov
Overview
The Drug Development Tools Research Grants (U01), with the option for Clinical Trials, is a funding opportunity that aims to support ongoing research. The main focus of this grant is the advancement of drug development tools already acknowledged by a Letter of Intent (LOI) within a qualification program by either the Center for Biologics Evaluation and Research (CBER) or the Center for Drug Evaluation and Research (CDER). The goal of these grants is to assist in the further development of these tools, which after qualification, will be made accessible to the public to address existing gaps in drug development.
Show More
Key Dates
Open Date: February 12, 2024
Application Due Date: May 13, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments(Federally recognized)
- Public housing authorities/ Indian housing authorities
- Native American tribal organizations(other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS
- other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others